Archives

by in
Entry Author Date Location
Medicines Buys ProFibrix, Led by Former Zymonite, for $90M 08/05/13 Seattle
The Immunex Alumni, Hood Wins Russ Prize, Williams Grabs Biogen Gig, & More Seattle-Area Life Sciences News 01/06/11 Seattle
Omeros Gets Drugs for Bleeding 01/05/11 Seattle
ZymoGenetics CEO Doug Williams Exits the Stage, Mulls Next Free Agent Move 11/08/10 Seattle
ZymoGenetics Regains Full U.S. Rights to Recothrom as Bayer Walks Away 12/21/09 Seattle
Zymo Drug Gets Canadian Approval 12/16/09 Seattle
Zymo Application Yanked in EU 12/14/09 Seattle
ZymoGenetics, King Pharma Brawl Over Drugs to Control Surgical Bleeding 11/09/09 Seattle
ZymoGenetics’ Former Medical Boss Leads Rival Startup, ProFibrix, With Drug For Bleeding 10/26/09 Seattle
ZymoGenetics Plays Hardball, Targeted Genetics’ Legacy, Omeros Preps for Fall IPO, & More Seattle-Area Life Sciences News 08/27/09 Seattle
ZymoGenetics, Citing Two Patient Deaths, Builds Up Ammunition for Case Against Rival 08/20/09 Seattle
ZymoGenetics Plays Hardball, Asks FDA to Pull Competing Drug Off Market Because of Safety 08/20/09 Seattle
Zymo Gets $6M in Q2 Recothrom Sales 08/03/09 Seattle
Dendreon’s Hiring Binge, Calistoga’s Venture Round, ZymoGenetics Unloads Drugs, & More Seattle-Area Life Sciences News 05/07/09 Seattle
ZymoGenetics Drug Sales Still Slumping After Full Year on Market 05/05/09 Seattle
ZymoGenetics Clamps Down on Losses, Predicts Climbing Recothrom Sales 02/11/09 Seattle
ZymoGenetics’ New Boss Sees Parallels to Dark Days at Immunex 01/05/09 Seattle
ZymoGenetics Drug For Surgical Bleeding Demonstrates Safety in Trial 12/08/08 Seattle
ZymoGenetics Cash Gets Lean, Recothrom Sales Still Slow 11/04/08 Seattle
ZymoGenetics Drug For Hepatitis C Kills Virus with Minimal Side Effects 11/03/08 Seattle
ZymoGenetics, Bayer Drug Vying for European Regulatory Approval 09/02/08 Seattle
ZymoGenetics Drug Getting Off to Slow Start in Marketplace 08/06/08 Seattle
ZymoGenetics Receives $100 Million Commitment From Deerfield 06/30/08 Seattle
Page 1 of 1